Table I.
Demographic, clinical and histopathological characteristics of patients with bladder carcinoma.a
| Category | n | % |
|---|---|---|
| Total patients | 92 | 100.0 |
| Gender | ||
| Male | 73 | 79.3 |
| Female | 19 | 20.7 |
| Ageb, years | ||
| <71 | 44 | 47.8 |
| ≥71 | 48 | 52.2 |
| Tumor | ||
| Primary | 80 | 87.0 |
| Recurrent | 12 | 13.0 |
| Voided urine cytology | ||
| Positive | 78 | 84.8 |
| Negative | 11 | 12.0 |
| Not evaluable | 3 | 3.2 |
| Tumor stage | ||
| pTa | 46 | 50.0 |
| pT1 | 21 | 22.8 |
| pTIS | 11 | 12.0 |
| pTIS only | 1 | 1.2 |
| +pTa | 2 | 2.2 |
| +pT1 | 4 | 4.3 |
| +≥pT2a | 4 | 4.3 |
| ≥pT2a | 14 | 15.2 |
| Concomitant PCa | ||
| Yes | 9 | 9.8 |
| No | 83 | 90.2 |
| Tumor grade (WHO 2004) | ||
| Low | 17 | 18.5 |
| High | 75 | 81.5 |
| Tumor gradec (WHO 1973) | ||
| G1 | 16 | 17.5 |
| G2 | 40 | 44.0 |
| G3 | 35 | 38.5 |
a
A total of 92 BCa patients were included in the present study. Among them were patients with primary and recurrent disease, and various tumor stages and grades. The table shows absolute and relative distribution of gender, age and clinicopathological parameters.
b
Dichotomized at median.
c
Tumor grade was available for only 91 patients. TIS, carcinoma in situ; PCa, prostate cancer. WHO, World Health Organization.